[1]
Hagan, J. 2021. Letter to the Editor: A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine. Kansas Journal of Medicine. 13, S2 (Mar. 2021), 29–30. DOI:https://doi.org/10.17161/kjm.vol1315733.